BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1376185)

  • 41. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Leblanc P; Symann ML
    Cancer Res; 1994 Jul; 54(14):3800-7. PubMed ID: 7913409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Economic costs of autotransplantation of hematopoietic progenitors].
    de Arriba F; Heras I; del Carmen Garcia M; Moraleda JM; Funes C; Ferrer F; Vicente V
    Med Clin (Barc); 1996 Mar; 106(9):329-32. PubMed ID: 8667698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
    Douay L; Gorin NC; Mary JY; Lemarie E; Lopez M; Najman A; Stachowiak J; Giarratana MC; Baillou C; Salmon C
    Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polyclonal engraftment after unrelated donor bone marrow and cord blood transplantation.
    Davies SM; Radloff GA; Wagner JE; McGlennen R; Kersey JH; Ramsay NK
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):304-9. PubMed ID: 9502297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system.
    Hirao A; Kawano Y; Takaue Y; Suzue T; Abe T; Sato J; Saito S; Okamoto Y; Makimoto A; Kawahito M
    Exp Hematol; 1994 Jun; 22(6):521-6. PubMed ID: 8187849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma.
    Brandwein JM; Callum J; Sutcliffe SB; Scott JG; Keating A
    Bone Marrow Transplant; 1990 Nov; 6(5):291-4. PubMed ID: 2291991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
    Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
    Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumours.
    Nieboer P; de Vries EG; Mulder NH; Sleijfer DT; Willemse PH; Hospers GA; Gietema JA; Sluiter WJ; van Der Graaf WT
    Bone Marrow Transplant; 2001 May; 27(9):959-66. PubMed ID: 11436106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flow cytometric quantitation of circulating hematopoietic progenitor cells in breast cancer patients on chemotherapy.
    Read EJ; O'Shaughnessy JA; Yu MY; Cottler-Fox M; Denicoff AM; Cowan KH; Gress RE
    Prog Clin Biol Res; 1992; 377():523-30. PubMed ID: 1279720
    [No Abstract]   [Full Text] [Related]  

  • 50. CD34+ cell dose and CD33- subsets: collection and engraftment kinetics in autologous peripheral blood stem cells transplantation.
    Sampol Mayol A; Besalduch Vital J; Galmés Llodrá A; Bargay Lleonart J; Matamoros Flori N; Morey Sureda M; Novo García A; Mascaró Riera M; Gonzaléz Bach E; Martínez García P
    Haematologica; 1998 Jun; 83(6):489-95. PubMed ID: 9676020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantation.
    Ito C; Sato H; Ando K; Watanabe S; Yoshiba F; Kishi K; Furuya A; Shitara K; Sugimoto S; Kohno H; Hiraoka A; Hotta T
    Bone Marrow Transplant; 2003 Aug; 32(4):391-8. PubMed ID: 12900775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Kessinger A; Coccia PF; Anderson J; Oldham FB; Epstein C; Armitage JO
    Bone Marrow Transplant; 1991 Feb; 7(2):139-43. PubMed ID: 1675592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral stem cell collection and transplantation in pediatric patients.
    Handgretinger R; Klingebiel T; Dopfer R; Siedner R; Baden B; Wendt S; Scheel-Walter HG; Scheel P; Schlander M; Niethammer D
    Prog Clin Biol Res; 1992; 377():615-20. PubMed ID: 1359568
    [No Abstract]   [Full Text] [Related]  

  • 54. Autologous and allogeneic transplantation with peripheral blood stem cells.
    Kessinger A
    Prog Clin Biol Res; 1992; 377():603-10; discussion 611-3. PubMed ID: 1359567
    [No Abstract]   [Full Text] [Related]  

  • 55. Autologous blood stem cell versus bone marrow transplantation.
    Körbling M; Juttner C; Henon P; Kessinger A
    Bone Marrow Transplant; 1992; 10 Suppl 1():144-8. PubMed ID: 1355683
    [No Abstract]   [Full Text] [Related]  

  • 56. Infusion of a high number of CD34+ cells provides a rapid hematopoietic recovery and cost savings in autologous peripheral blood stem cell transplantation.
    Ashihara E; Shimazaki C; Okano A; Hatsuse M; Okamoto A; Shimura K; Takahashi R; Sumikuma T; Inaba T; Fujita N; Murakami S; Haruyama H; Nakagawa M
    Jpn J Clin Oncol; 2002 Apr; 32(4):135-9. PubMed ID: 12072423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peripheral hematopoietic stem cell transplantation: current concepts.
    Lowry PA; Tabbara IA
    Exp Hematol; 1992 Sep; 20(8):937-42. PubMed ID: 1354619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. B-cell proliferative and differentiative responses after autologous peripheral blood stem cell or bone marrow transplantation.
    Kiesel S; Pezzutto A; Moldenhauer G; Haas R; Körbling M; Hunstein W; Dörken B
    Blood; 1988 Aug; 72(2):672-8. PubMed ID: 2900031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hematopoietic recovery following autologous bone marrow transplantation: role of cryopreservation, number of cells infused and nature of high-dose chemotherapy.
    Hartmann O; Beaujean F; Bayet S; Pico JL; Tournade MF; Lemerle ; Parmentier C
    Eur J Cancer Clin Oncol; 1985 Jan; 21(1):53-60. PubMed ID: 3882431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Do CD34+ cell counts predict haemopoietic recovery after autologous blood stem cell transplantation (ABSCT)?
    Mijovic A; Mufti GJ
    Br J Haematol; 1995 Jan; 89(1):226-7. PubMed ID: 7530478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.